Search

Your search keyword '"Afd Pharmacoepi ' showing total 4,454 results

Search Constraints

Start Over You searched for: Author "Afd Pharmacoepi Remove constraint Author: "Afd Pharmacoepi
4,454 results on '"Afd Pharmacoepi '

Search Results

2. Are novel oral oncolytics underdosed in obese patients?

3. Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned

4. The risk of delirium after sedation with propofol or midazolam in intensive care unit patients

5. Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study

6. A blueprint for health technology assessment capacity building: lessons learned from Malta

7. A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes

9. Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate

10. Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study

11. Fracture patterns in adult onset type 1 diabetes and associated risk factors - A nationwide cohort study

13. Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data

14. Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer

15. Cognitive processes in pharmacists’ clinical decision-making

16. Forging new paths in access to medicines research: Towards equitable access for all

17. Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs

18. Lifecycle HTA: Promising applications and a framework for implementation

19. Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review

20. Impact of Drug Recalls on Patients in The Netherlands: A 5-Year Retrospective Data Analysis

22. A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens

23. Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients

24. The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews

25. ABCB1 attenuates brain exposure to the KRASG12C inhibitor opnurasib whereas binding to mouse carboxylesterase 1c influences its plasma exposure

26. Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration

27. Towards Consistency in Dietary Pattern Scoring: Standardising Scoring Workflows for Mediterranean, DASH, and MIND Diets Using 24-Hour Recall and Two Variations of a Food Frequency Questionnaire

28. Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review

29. The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome

31. Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of the antimalarial drug pyronaridine in human whole blood

32. A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases

34. Predictability of human exposure by human-CYP3A4-transgenic mouse models: A meta-analysis

36. Improving expert search effectiveness: Comparing ways to rank and present search results

37. Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study

38. Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study

40. Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023

41. Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation

42. Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries

43. Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions: A cross-sectional study in six EU member states

44. The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib

45. Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam

46. A case report: Management of carbamazepine intoxication using hemodialysis followed by continuous venovenous hemodialysis

47. Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis

48. Rol voor openbaar apotheker als behandelaar bij recidiverende blaasontsteking?

49. Adoption of new medicines in primary care: A comparison between the uptake of new oral anticoagulants and diabetes medicines

50. Uptake of orphan drugs in the WHO essential medicines lists

Catalog

Books, media, physical & digital resources